Quantitative Analysis of ErbB1 and ErbB2 Genes Amplification by a High Performance Liquid Chromatography

Background Genes for human epidermal growth factor receptors B1 (ErbB1) and B2 (ErbB2) were amplified in breast and ovarian cancers. Both of them were associated with aggressive disease and worse prognosis. The ErbB1 or ErbB2 status of a tumor may provide an indication of the response to ErbB1 and ErbB2 -targeted therapies. For accurate and rapid assessment of amplification of ErbB1 and ErbB2 oncogenes, a High Performance Liquid Chromatography (HPLC) method was developed in this study. Methods DNA was extracted from 30 primary breast tumors and 20 blood samples of healthy donors. ErbB1 and ErbB2 genes along with a reference gene were co-amplificated by Polymerase Chain Reaction (PCR). The PCR products were separated and quantified using an anion-exchange column within 30 min and in a single step. Optimum resolution was obtained when a sodium chloride gradient and a column temperature of 35°C were used. The results of HPLC analysis of ErbB1 and ErbB2 PCR products were compared with real time PCR method as a gold standard test for 7 tumor samples. Results The proposed HPLC method was confirmed by real time PCR method. Twenty two and ten of the specimens in our breast cancer cohort showed more than a two-fold amplification of ErbB2 and ErbB1 oncogenes, respectively. Conclusion Our results were confirmed by real time PCR and showed that HPLC method is a specific, cheap and clinically applicable analytical approach for assessment of ErbB1 and ErbB2 statuses in breast tumors.

• Publication year

  2014

• Venue

  Avicenna journal of medical biotechnology

• Publication date

  2014-11-21

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 25414785PMCID 4224662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of Gene Copy Number Variations using a Method Based on Lab-on-a-Chip Technology

  2012cited by this paper
• Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma

  2011cited by this paper
• Lapatinib in breast cancer - the predictive significance of HER1 (EGFR), HER2, PTEN and PIK3CA genes and lapatinib plasma level assessment.

  2010cited by this paper
• Type I receptor tyrosine kinases as predictive or prognostic markers in early breast cancer.

  2008cited by this paper
• Trastuzumab--mechanism of action and use in clinical practice.

  2007cited by this paper
• EGFR gene and protein expression in breast cancers.

  2007cited by this paper
• Separation of topological forms of plasmid DNA by anion-exchange HPLC: shifts in elution order of linear DNA.

  2007cited by this paper
• The EGF receptor family: spearheading a merger of signaling and therapeutics.

  2007cited by this paper
• The ErbB2 Signaling Network as a Target for Breast Cancer Therapy

  2006cited by this paper
• Assessing epidermal growth factor receptor expression in tumours: what is the value of current test methods?

  2005cited by this paper
• Detection of differential gene copy number using denaturing high performance liquid chromatography.

  2005cited by this paper
• Outcome and human epidermal growth factor receptor (HER) 1–4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling

  2004cited by this paper
• Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

  2004cited by this paper
• EGFR and cancer prognosis.

  2001cited by this paper
• Analysis and purification of nucleic acids by ion-pair reversed-phase high-performance liquid chromatography.

  2000cited by this paper
• Effect of temperature on the separation of DNA fragments by high-performance liquid chromatography and capillary electrophoresis: a comparative study.

  2000cited by this paper
• Molecular mechanisms underlying ErbB2/HER2 action in breast cancer

  2000cited by this paper
• Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry.

  2000cited by this paper
• Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer

  1995cited by this paper
• Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissues and comparison to cellular DNA content.

  1995cited by this paper
• Rapid quantitative analysis of differential PCR products by high-performance liquid chromatography.

  1993influential reference
• Rapid analysis and quantitation of PCR products by high-performance liquid chromatography.

  1991cited by this paper
• Short protocols in molecular biology

  1990cited by this paper
• Correlation of erbB-2 gene amplification with low levels of estrogen and/or progesterone receptors in primary breast cancer: do erbB-2 products delineate hormone-independent tumors?

  1989cited by this paper

• Synergistic Role of MoO₃–CTAB Nanostructures in Boosting Electrochemical Immunosensing of HER2

  2026cites this paper
• Molecular studies of breast cancer in Iran: A Systematic Review

  2020influential citation
• Exosome-mediated crosstalk stimulated by liver fluke granulin promotes a microenvironment conducive to cholangiocarcinoma

  2019cites this paper